Cargando…
Evaluation of tumor-infiltrating lymphocytes (TILs) in molecular subtypes of an Indian cohort of breast cancer patients
OBJECTIVES: Evaluation of tumor-infiltrating lymphocytes (TILs) distribution in an Indian cohort of breast cancer patients for its prognostic significance. METHODS: A retrospective cohort of breast cancer patients from a single onco-surgeon’s breast cancer clinic with a uniform treatment strategy wa...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677664/ https://www.ncbi.nlm.nih.gov/pubmed/36411483 http://dx.doi.org/10.1186/s13000-022-01271-y |
_version_ | 1784833853895999488 |
---|---|
author | Vaid, Pooja M. Puntambekar, Anirudha K. Jumle, Nutan S. Banale, Rituja A. Ansari, Danish Reddy, Ruhi R. Unde, Rohini R. Namewar, Namrata P. Kelkar, Devaki A. Shashidhara, L. S. Koppiker, Chaitanyanand B. Kulkarni, Madhura D. |
author_facet | Vaid, Pooja M. Puntambekar, Anirudha K. Jumle, Nutan S. Banale, Rituja A. Ansari, Danish Reddy, Ruhi R. Unde, Rohini R. Namewar, Namrata P. Kelkar, Devaki A. Shashidhara, L. S. Koppiker, Chaitanyanand B. Kulkarni, Madhura D. |
author_sort | Vaid, Pooja M. |
collection | PubMed |
description | OBJECTIVES: Evaluation of tumor-infiltrating lymphocytes (TILs) distribution in an Indian cohort of breast cancer patients for its prognostic significance. METHODS: A retrospective cohort of breast cancer patients from a single onco-surgeon’s breast cancer clinic with a uniform treatment strategy was evaluated for TILs. Tumor sections were H&E stained and scored for the spatial distribution and percent stromal TILs infiltration by a certified pathologist. The scores were analysed for association with treatment response and survival outcomes across molecular subtypes. RESULTS: Total 229 breast cancer tumors were evaluated. Within spatial distribution categories, intra-tumoral TILs were observed to be associated with complete pathological response and lower recurrence frequency for the entire cohort. Subtype-wise analysis of stromal TILs (sTILs) re-enforced significantly higher infiltration in TNBC compared to HER2-positive and ER-positive tumors. A favourable association of higher stromal infiltration was observed with treatment response and disease outcomes, specifically in TNBC. CONCLUSION: Intra-tumoral TILs showed a higher proportion with favourable association with better patient outcomes in an Indian cohort, unlike western cohorts where both stromal and intra-tumoral TILs show similar association with prognosis. With further validation, TILs can be developed as a cost-effective surrogate marker for treatment response, especially in a low-resource setting such as India. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13000-022-01271-y. |
format | Online Article Text |
id | pubmed-9677664 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-96776642022-11-22 Evaluation of tumor-infiltrating lymphocytes (TILs) in molecular subtypes of an Indian cohort of breast cancer patients Vaid, Pooja M. Puntambekar, Anirudha K. Jumle, Nutan S. Banale, Rituja A. Ansari, Danish Reddy, Ruhi R. Unde, Rohini R. Namewar, Namrata P. Kelkar, Devaki A. Shashidhara, L. S. Koppiker, Chaitanyanand B. Kulkarni, Madhura D. Diagn Pathol Research OBJECTIVES: Evaluation of tumor-infiltrating lymphocytes (TILs) distribution in an Indian cohort of breast cancer patients for its prognostic significance. METHODS: A retrospective cohort of breast cancer patients from a single onco-surgeon’s breast cancer clinic with a uniform treatment strategy was evaluated for TILs. Tumor sections were H&E stained and scored for the spatial distribution and percent stromal TILs infiltration by a certified pathologist. The scores were analysed for association with treatment response and survival outcomes across molecular subtypes. RESULTS: Total 229 breast cancer tumors were evaluated. Within spatial distribution categories, intra-tumoral TILs were observed to be associated with complete pathological response and lower recurrence frequency for the entire cohort. Subtype-wise analysis of stromal TILs (sTILs) re-enforced significantly higher infiltration in TNBC compared to HER2-positive and ER-positive tumors. A favourable association of higher stromal infiltration was observed with treatment response and disease outcomes, specifically in TNBC. CONCLUSION: Intra-tumoral TILs showed a higher proportion with favourable association with better patient outcomes in an Indian cohort, unlike western cohorts where both stromal and intra-tumoral TILs show similar association with prognosis. With further validation, TILs can be developed as a cost-effective surrogate marker for treatment response, especially in a low-resource setting such as India. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13000-022-01271-y. BioMed Central 2022-11-21 /pmc/articles/PMC9677664/ /pubmed/36411483 http://dx.doi.org/10.1186/s13000-022-01271-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Vaid, Pooja M. Puntambekar, Anirudha K. Jumle, Nutan S. Banale, Rituja A. Ansari, Danish Reddy, Ruhi R. Unde, Rohini R. Namewar, Namrata P. Kelkar, Devaki A. Shashidhara, L. S. Koppiker, Chaitanyanand B. Kulkarni, Madhura D. Evaluation of tumor-infiltrating lymphocytes (TILs) in molecular subtypes of an Indian cohort of breast cancer patients |
title | Evaluation of tumor-infiltrating lymphocytes (TILs) in molecular subtypes of an Indian cohort of breast cancer patients |
title_full | Evaluation of tumor-infiltrating lymphocytes (TILs) in molecular subtypes of an Indian cohort of breast cancer patients |
title_fullStr | Evaluation of tumor-infiltrating lymphocytes (TILs) in molecular subtypes of an Indian cohort of breast cancer patients |
title_full_unstemmed | Evaluation of tumor-infiltrating lymphocytes (TILs) in molecular subtypes of an Indian cohort of breast cancer patients |
title_short | Evaluation of tumor-infiltrating lymphocytes (TILs) in molecular subtypes of an Indian cohort of breast cancer patients |
title_sort | evaluation of tumor-infiltrating lymphocytes (tils) in molecular subtypes of an indian cohort of breast cancer patients |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677664/ https://www.ncbi.nlm.nih.gov/pubmed/36411483 http://dx.doi.org/10.1186/s13000-022-01271-y |
work_keys_str_mv | AT vaidpoojam evaluationoftumorinfiltratinglymphocytestilsinmolecularsubtypesofanindiancohortofbreastcancerpatients AT puntambekaranirudhak evaluationoftumorinfiltratinglymphocytestilsinmolecularsubtypesofanindiancohortofbreastcancerpatients AT jumlenutans evaluationoftumorinfiltratinglymphocytestilsinmolecularsubtypesofanindiancohortofbreastcancerpatients AT banaleritujaa evaluationoftumorinfiltratinglymphocytestilsinmolecularsubtypesofanindiancohortofbreastcancerpatients AT ansaridanish evaluationoftumorinfiltratinglymphocytestilsinmolecularsubtypesofanindiancohortofbreastcancerpatients AT reddyruhir evaluationoftumorinfiltratinglymphocytestilsinmolecularsubtypesofanindiancohortofbreastcancerpatients AT underohinir evaluationoftumorinfiltratinglymphocytestilsinmolecularsubtypesofanindiancohortofbreastcancerpatients AT namewarnamratap evaluationoftumorinfiltratinglymphocytestilsinmolecularsubtypesofanindiancohortofbreastcancerpatients AT kelkardevakia evaluationoftumorinfiltratinglymphocytestilsinmolecularsubtypesofanindiancohortofbreastcancerpatients AT shashidharals evaluationoftumorinfiltratinglymphocytestilsinmolecularsubtypesofanindiancohortofbreastcancerpatients AT koppikerchaitanyanandb evaluationoftumorinfiltratinglymphocytestilsinmolecularsubtypesofanindiancohortofbreastcancerpatients AT kulkarnimadhurad evaluationoftumorinfiltratinglymphocytestilsinmolecularsubtypesofanindiancohortofbreastcancerpatients |